MTOR and cancer: The cell cycle analysis shows enrichment for the EMT signature in G1-arrested cancer cells while the PI3K-AKT-mTOR signalling was active in cycling cells (Fig. S2), consistent with the scRNA-seq analysis of patient samples (GSE140042) and bulk RNA-seq studies.